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NOTES AND COMMENTS 
Summary Report—Antimicrobial Susceptibility 
Tests Results from Henry Ford Hospital Compared With 
Others Nationally, January-June 1969. 
Thomas R. .Neblett. Ph.D., Jeanne .Schott, M.S., and John F. Eisses, Ph.D.* 
Late in 1968 this hospital became 
•. pai Meipant in an evaluation program 
inaugurated by Bristol Laboratories to 
I test antibiotic susceptibility. Our labor-
I atory. and those from 24 other com-
parable institutions, submited zone size 
I data monthly on bacterial isolates from 
all services, in-patient and out-patient 
[Jcpanments. We utilized a standard 
tonn designed for raw data input by 
I photo-seanning. Approximately two 
alter month-end each participat-
ing laboratory received, from the Fish-
|;r-Stevens Institute of Clifton. New 
Jersey, a computer print-out giving 
h«nsitivity percentages by clinical serv-
« and for the hospital over-all. Na-
'lonal results were compiled from the 
"•er-all data, irrespective of clinical 
I '"^ rx-ice. 
The monthly computer reports fur-
fed total numbers of a particular 
l^ icro-organism isolated, numbers from 
total tested against each drug and 
•* per cent of the number tested that 
sensitive. Sensitivity data sub-
5«eriology-Serology Di 
^ « of Pathology 
vision. Depart-
mitted from our laboratory were ob-
tained by the single high concentration 
disc method of testing, while the na-
tional data include percentages arrived 
at by all test methods. We reported or-
ganisms to the computer center as be-
ing either sensitive or resistant. Those 
which would be classified by their zone 
size as having intermediate sensitivity' 
were tallied with the resistant group. 
Zone size criteria for sensitivity to 
drugs included in this report are listed 
in Table I I . 
Table I includes the six micro-organ-
isms most frequently isolated in the 
clinical bacteriology laboratory and 
their monthly frequency for the six 
months period. Table I I I is a summary 
by month of the sensitivity percentages 
of each organism to 10 commonly used 
drugs. 
Participation in this program has 
had the advantage of enabling us to 
maintain a monthly surveillance on 
possible sensitivity changes to certain 
drugs, and the usage data serve ad-
junctly to the selection of drugs in the 
laboratory test scheme. 
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TABLE 1 
BACTERIA ISOLATED MOST FREQUENTLY 
IN CLINICAL MICROBIOLOGY 
JAN FEB MAR APR MAY JUN TOTAL 
Escherichia coli 
HFH 344 98 525 345 349 156 1,817 
NAT'L' 2,994 1,290 2,093 1,533 914 1,280 10,104 
Enterobacter sp. HFH 185 36 197 178 131 56 783 NAT'L 1,627 692 1,036 769 498 840 5,462 
Staph, aureus HFH 183 40 268 159 165 75 890 
NAT'L 1.518 642 1,039 675 560 629 5,063 
Proteus sp. HFH 93 33 167 42 27 36 398 
NAT'L 899 379 426 544 249 750 3,247 
Pseudomonas sp. HFH 88 19 103 73 71 36 390 
NAT'L 791 254 483 384 262 383 2,557 
Strep, faecalls HFH 56 18 110 74 53 22 333 
NAT'L 552 333 755 472 218 123 2,453 
30 
• Ni.>\ior>a\ Totat i nc t v ides H . F . H . Data . 
MaWonaV T o \ a \ Vrvctv i r te^ H . F . H . D a t a . 
TABLE II 




DRUG DISC POTENCY (meg) SIZE (mm) 
AMPICILLIN 10 
STAPHYLOCOCCUS 29 
ALL OTHERS 14 
CEPHALOTHIN 30 18 
CHLORAMPHENICOL 30 18 
COLISTIN 10 11 
ERYTHROMYCIN 15 18 
KANAMYCIN 30 18 
LINCOMYCIN 2 16 
METHICILLIN 5 14 
STREPTOMYCIN 10 15 
TETRACYCLINE 30 19 
TABLE III 
PERCENT SENSITIVITY, 
MOST FREQUENT ISOLATE VS. ANTIMICROBIAL DRUG. 
HENRY FORD HOSPITAL COMPARED TO NATIONWIDE VALUES 
Escherichia coli Enterobacter so. Staph, aureus 
; MONTH 1 2 3 4 5 6 1 2 3 4 5 6 1 2 3 4 5 6 
AMPICILUN H 78.2 82.6 73.7 ill 84.8 78.2 24.3 16.7 27.9 23.0 22.9 30.4 33.3 30.8 27.6 25.5 25.4 28.0 
N 64.0 (fi.i 68.2 75.2 72.6 74.7 13.0 13.6 17.3 1L7 13.8 9.6 37.0 42.3 4L2 1 49.9 46.5 35.8 
CEPHALOTHIN H 86.3 88.8 84.8 80.6 82.5 92.0 67.0 50.0 54.3 69.1 64.1 64.8 98.3 100.0 98.9 100.0 100.0 100.0 
N 82.1 83.2 '8L8 84.1 85.4 88.4 53.5 66.1 62.1 53.9 63.3 5L6 99.2 99.8 98.9 99.7 99.6 100.0 
CHLORAMPHENICOL H 95.6 98.0 36.1 96.8 98.0 93.1 81.8 82.7 83.2 85.2 86.3 87.8 97.8 100.0 98.5 98.1 98.8 100.0 N 83.8 8L1 87.4 94.3 95.7 92.5 7L2 66.8 72.8 7n." 80.3 73.6 98.0 98.4 97.2 98.8 99.3 99.4 
COLISTIN H 95.5 99.0 97.8 96.4 98.5 98.6 89.4 97.2 90.3 93.7 97.0 94.5 o tt tt tt • 
N 94.4 95.7 96.0 96.3 98.5 98.0 84.7 91.2 92.4 91.6 96.2 90.1 6.4 10.0 9.5 7.0 tt 7.1 
ERYTHROMYCIN H • • 85.7 83.3 
tt 
• - - * « - - 89.2 97.4 92.1 95.4 93.4 93.9 
N 88.9 • 75.0 75.0 100.0 92.3 50.0 » 46.2 tt 91.0 92.9 95.5 Q5.4 94.4 89.2 
KANAMYCIN H 88.9 82.2 83.5 72.6 88.1 90.5 72.5 66.7 70.7 64.6 76.2 75.0 • • • 
tt • • 
N 83.7 82.4 86.2 86.6 88.4 90.5 78.7 78.8 76.0 74.4 73.8 72.7 96.3 98.3 97.4 97.7 91.9 98.6~1 
LINCOMYCIN H • • • • 83.3 • - -
tt tt 
- - 9L1 97.4 90.1 85.4 '10. q 88.7 
N 70.0 7L4 8L8 tt 90.0 81.8 • « 80.0 • * • 93.9 97.4 95.2 92.3 93.0 94.0 
100.0 METHICILUN H • • • « • • - - « * - - 96.0 84.2 93.3 98.7 96.9 
N 100.0 • • 100.0 tt - - tt - 0.0 97.6 97.5 92.4 97.5 98.3 97.7 
TETRACYCLINE H • • 91.7 « • 
0 
• - « tt • • - - - - - -
N 64.0 63.5 63.4 73.1 75.3 •70.5 54.9 53.5 55.2 62.0 70.5 61.8 86.0 9L1 91.8 90.5 94.4 89.4 
SIREPTOMYCIN H 67.0 66.3 59.7 52.8 65.0 60.2 59.4 59.4 62.9 5L8 70.4 66.0 tt tt • * • • 
N 51.2 A/1.7 56.3 63.6 68.4 1 63.6 52.9 47.0 55.4 57.0 59.5 55.9 8 2 ^ 77.5 9L5 86.9 77.9 83.1 
ro 
o 
VI' n r r 5 1 . 2 \44.7 156.3 165.0 1 OB." 
TABLE III — Continued 
Proteus sp. Pseudomonas s ). Strep, laecalis 
MONTH 1 2 3 4 5 6 1 2 3 4 5 6 1 2 3 4 1 5 16 
AMPICILUN H 58.3 
tt 48.8 50.0 33.3 • 9.2 0.0 5.9 L4 7.0 11.1 94.6 100.00 91.8 89.2 98.0 I 95.5 
N 62.8 70.7 57.5 64.5 64.3 65.3 6.3 7.5 11.2 4.4 8.0 6.4 94.6 85. 1 79.3 81.4 85.5 1 85.7 
CEPHALOTHIN H 62.5 • 58.4 40.5 33.3 * 10.2 0.0 3.9 ~ L 4 ^ 0.0 14.3 67.9 41.2 38.5 27.4 28.3 36.4 
N 66.5 73.9 62.8 64.8 
90.5 
67.8 66.9 5.4 5.2 11.1 4.5 4.6 5.1 88.6 82.6 75.0 72.0 65.6 78.0 
CHLORAMPHENICOL H 73.9 
« 87.5 80.8 • 24.1 5.6 15.5 8.3 13.0 17.1 76.4 94.1 80.9 65.8 61.5 71.4 
N 76.3 77.6 68.1 83.1 84.6 85.4 19.6 22.2 29.2 22.9 26.2 12.2 77.5 82.8 81.6 82.4 82.8 86.8 
COLISTIN H 26.1 » 17.5 7.5 I L l 
tt 93.2 94.7 94.1 94.5 97.2 91.7 - • tt tt « 
N 8.0 10.3 9.0 8.1 13.5 10.9 93.5 92.8 95.7 94.4 93.2 92.1 9.9 91.5 62.9 42.5 91.2 46.0 
ERYTHROMYCIN H • - - -
tt tt 
- - - -
tt 68.7 93.8 72.9 59.7 46.9 50.0 





KANAMYCIN H 73.9 • 93.6 72.5 85.2 • 16.2 6.2 7.3 4.4 L4 14.3 - - • • 
N 87.5 SS. 1 92.0 87.0 S5.9 88.7 25.2 33.7 35.5 28.6 27.3 28. 7 41,6 58.1 57.2 59.2 40.7 
5.8 
73.8 
4.8 LINCOMYCIN H - • - - - -
tt 
- - - - - 3L6 0.0 1 1.9 2.9 
N • • • _ 1 • * - • - - • 12.7 15.3 24.3 27.0 30.1 24.6 
METHICILUN H - • - - - - » - - - - - 0.0 1 6.7 1.9 3.0 7.7 15.0 




• - • - - • - • - - - - _ - _ -
N 12.0 20.7 13.1 16.4 10.9 17.3 36.3 52.0 24.1 23.4 15.2 33.3 49.4 55.9 63.5 69.8 52.4 
STREPTOMYCIN H 
79.2 =• 85.0 69.1 70.8 • 10.5 11.1 12.6 2.8 8.3 26.7 - - • • * • 
N 62.0 1 59.8 68.3 65.3 67.2 69.1 3L2 19.4 28.7 25.9 15.4 29.0 8.1 42.9 33.3 17.2 43.4 20.0 
(O 
V*J 
Not tested. H 
Fewer than 10 isolates tested. N 
Henry Ford Hospital. 
National. 

